STOCK TITAN

LifeStance (NASDAQ: LFST) director receives 35,492 restricted stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LifeStance Health Group, Inc. director Lori Goltermann reported an equity compensation award. On July 2, 2026, she acquired 35,492 shares of common stock at $0.00 per share through a grant classified as restricted stock units (RSUs). Following this award, she directly holds 35,492 shares, all represented by RSUs, each of which entitles her to receive one share of LifeStance common stock if vesting conditions are met.

Positive

  • None.

Negative

  • None.
Insider Goltermann Lori
Role null
Type Security Shares Price Value
Grant/Award Common Stock 35,492 $0.00 --
Holdings After Transaction: Common Stock — 35,492 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSUs granted 35,492 units Restricted stock unit award reported on July 2, 2026
Grant price per share $0.00 per share Equity award to director Lori Goltermann
Shares held after grant 35,492 shares Total direct holdings following the RSU award
restricted stock units financial
"Includes 35,492 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Includes 35,492 restricted stock units ("RSUs"). Each RSU represents a contingent right"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
grant/award acquisition financial
"transaction_action: "grant/award acquisition" for the 35,492-share RSU award"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did LifeStance (LFST) report for Lori Goltermann?

LifeStance director Lori Goltermann received an equity grant of 35,492 restricted stock units. These RSUs were awarded at no cash cost and each unit represents a contingent right to receive one share of LifeStance common stock upon satisfaction of vesting conditions.

How many LifeStance (LFST) shares does Lori Goltermann hold after this Form 4?

After the reported grant, Lori Goltermann holds 35,492 LifeStance shares. All of these are in the form of restricted stock units, meaning they convert into common shares only if the specified vesting requirements are ultimately satisfied under the company’s equity plan.

Was Lori Goltermann’s LifeStance (LFST) award a market purchase or a compensation grant?

The 35,492 LifeStance shares were received as a compensation grant, not a market purchase. The Form 4 uses transaction code “A” for a grant or award, with a reported price of $0.00 per share, indicating no open-market buying occurred.

What does each restricted stock unit (RSU) for LifeStance (LFST) represent?

Each LifeStance RSU represents a contingent right to receive one share of common stock. The Form 4 footnote explains that the 35,492 units convert into an equal number of shares only when the applicable vesting and other plan conditions are fulfilled.

Is this LifeStance (LFST) Form 4 transaction a buy or sell signal?

The transaction reflects an equity grant, not a buy or sell trade. It is classified as an acquisition of 35,492 shares through a restricted stock unit award, a common form of director compensation that does not involve cash paid in the open market.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Goltermann Lori

(Last)(First)(Middle)
C/O LIFESTANCE HEALTH GROUP, INC.
4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)
SCOTTSDALE ARIZONA 85251

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/02/2026A35,492(1)A$0.0035,492D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes 35,492 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
By: /s/ Ryan Pardo, Attorney-in-Fact07/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)